SARS-CoV-2 Vaccine Response in Patients With Autoimmune Hepatitis

Patients suffering from autoimmune hepatitis, a chronic immune-mediated liver disease with an incidence of 0.9 to 2 per 100,000 population per year in Europe, are considered to have a particularly increased risk for coronavirus disease 2019 (Covid-19)-associated hospitalization and death.(1,2) Sever...

Descripción completa

Detalles Bibliográficos
Autores principales: Schneider, Lisa, Schubert, Lorenz, Winkler, Florian, Munda, Petra, Winkler, Stefan, Tobudic, Selma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: by the AGA Institute 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9040499/
https://www.ncbi.nlm.nih.gov/pubmed/35487452
http://dx.doi.org/10.1016/j.cgh.2022.04.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9040499/
https://www.ncbi.nlm.nih.gov/pubmed/35487452
http://dx.doi.org/10.1016/j.cgh.2022.04.006

Ejemplares similares